1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted

2. Executive Summary
2.1. Market Snapshot: Global Periodontal Therapeutics Market
2.2. Global Periodontal Therapeutics Market, By Therapeutic, 2023 (US$ Million)
2.3. Global Periodontal Therapeutics Market, By Geography, 2023 (US$ Million)
2.4. Attractive Investment Proposition by Geography, 2023

3. Periodontal Therapeutics Market: Competitive Analysis
3.1. Market Positioning of Key Periodontal Therapeutics Market Vendors
3.2. Strategies Adopted by Periodontal Therapeutics Market Vendors
3.3. Key Industry Strategies
3.4. Tier Analysis 2023 Versus 2032

4. Periodontal Therapeutics Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Periodontal Therapeutics Market Value, 2022 - 2032, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat Of Substitutes
4.6.4. Threat Of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape

5. Periodontal Therapeutics Market: By Therapeutic, 2022-2032, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2023 Versus 2032
5.3. Market Segmentation
5.3.1. Doxycycline
5.3.1.1. Minocycline
5.3.1.2. Metronidazole
5.3.1.3. Other Drugs
5.3.2. Local Antibodies
5.3.2.1. Arestin
5.3.2.2. Chlorhexidine
5.3.2.3. Other


6. North America Periodontal Therapeutics Market, 2022-2032, USD (Million)
6.1. Market Overview
6.2. Periodontal Therapeutics Market: By Therapeutic, 2022-2032, USD (Million)
6.3.Periodontal Therapeutics Market: By Region, 2022-2032, USD (Million)
6.3.1.North America
6.3.1.1. U.S.
6.3.1.1.1. Periodontal Therapeutics Market: By Therapeutic, 2022-2032, USD (Million)
6.3.1.2. Canada
6.3.1.2.1. Periodontal Therapeutics Market: By Therapeutic, 2022-2032, USD (Million)
6.3.1.3. Rest of North America
6.3.1.3.1. Periodontal Therapeutics Market: By Therapeutic, 2022-2032, USD (Million)

7. UK and European Union Periodontal Therapeutics Market, 2022-2032, USD (Million)
7.1. Market Overview
7.2. Periodontal Therapeutics Market: By Therapeutic, 2022-2032, USD (Million)
7.3.Periodontal Therapeutics Market: By Region, 2022-2032, USD (Million)
7.3.1.UK and European Union
7.3.1.1. UK
7.3.1.1.1. Periodontal Therapeutics Market: By Therapeutic, 2022-2032, USD (Million)
7.3.1.2. Germany
7.3.1.2.1. Periodontal Therapeutics Market: By Therapeutic, 2022-2032, USD (Million)
7.3.1.3. Spain
7.3.1.3.1. Periodontal Therapeutics Market: By Therapeutic, 2022-2032, USD (Million)
7.3.1.4. Italy
7.3.1.4.1. Periodontal Therapeutics Market: By Therapeutic, 2022-2032, USD (Million)
7.3.1.5. France
7.3.1.5.1. Periodontal Therapeutics Market: By Therapeutic, 2022-2032, USD (Million)
7.3.1.6. Rest of Europe
7.3.1.6.1. Periodontal Therapeutics Market: By Therapeutic, 2022-2032, USD (Million)

8. Asia Pacific Periodontal Therapeutics Market, 2022-2032, USD (Million)
8.1. Market Overview
8.2. Periodontal Therapeutics Market: By Therapeutic, 2022-2032, USD (Million)
8.3.Periodontal Therapeutics Market: By Region, 2022-2032, USD (Million)
8.3.1.Asia Pacific
8.3.1.1. China
8.3.1.1.1. Periodontal Therapeutics Market: By Therapeutic, 2022-2032, USD (Million)
8.3.1.2. Japan
8.3.1.2.1. Periodontal Therapeutics Market: By Therapeutic, 2022-2032, USD (Million)
8.3.1.3. India
8.3.1.3.1. Periodontal Therapeutics Market: By Therapeutic, 2022-2032, USD (Million)
8.3.1.4. Australia
8.3.1.4.1. Periodontal Therapeutics Market: By Therapeutic, 2022-2032, USD (Million)
8.3.1.5. South Korea
8.3.1.5.1. Periodontal Therapeutics Market: By Therapeutic, 2022-2032, USD (Million)
8.3.1.6. Rest of Asia Pacific
8.3.1.6.1. Periodontal Therapeutics Market: By Therapeutic, 2022-2032, USD (Million)

9. Latin America Periodontal Therapeutics Market, 2022-2032, USD (Million)
9.1. Market Overview
9.2. Periodontal Therapeutics Market: By Therapeutic, 2022-2032, USD (Million)
9.3.Periodontal Therapeutics Market: By Region, 2022-2032, USD (Million)
9.3.1.Latin America
9.3.1.1. Brazil
9.3.1.1.1. Periodontal Therapeutics Market: By Therapeutic, 2022-2032, USD (Million)
9.3.1.2. Mexico
9.3.1.2.1. Periodontal Therapeutics Market: By Therapeutic, 2022-2032, USD (Million)
9.3.1.3. Rest of Latin America
9.3.1.3.1. Periodontal Therapeutics Market: By Therapeutic, 2022-2032, USD (Million)

10. Middle East and Africa Periodontal Therapeutics Market, 2022-2032, USD (Million)
10.1. Market Overview
10.2. Periodontal Therapeutics Market: By Therapeutic, 2022-2032, USD (Million)
10.3.Periodontal Therapeutics Market: By Region, 2022-2032, USD (Million)
10.3.1.Middle East and Africa
10.3.1.1. GCC
10.3.1.1.1. Periodontal Therapeutics Market: By Therapeutic, 2022-2032, USD (Million)
10.3.1.2. Africa
10.3.1.2.1. Periodontal Therapeutics Market: By Therapeutic, 2022-2032, USD (Million)
10.3.1.3. Rest of Middle East and Africa
10.3.1.3.1. Periodontal Therapeutics Market: By Therapeutic, 2022-2032, USD (Million)

11. Company Profile
11.1. 3M
11.1.1. Company Overview
11.1.2. Financial Performance
11.1.3. Product Portfolio
11.1.4. Strategic Initiatives
11.2. Den-Mat Holdings, LLC
11.2.1. Company Overview
11.2.2. Financial Performance
11.2.3. Product Portfolio
11.2.4. Strategic Initiatives
11.3. Dexcel Pharma
11.3.1. Company Overview
11.3.2. Financial Performance
11.3.3. Product Portfolio
11.3.4. Strategic Initiatives
11.4. Galderma S.A.
11.4.1. Company Overview
11.4.2. Financial Performance
11.4.3. Product Portfolio
11.4.4. Strategic Initiatives
11.5. Kaken Pharmaceutical Co., Ltd.
11.5.1. Company Overview
11.5.2. Financial Performance
11.5.3. Product Portfolio
11.5.4. Strategic Initiatives
11.6. Valeant Pharmaceuticals International, Inc.
11.6.1. Company Overview
11.6.2. Financial Performance
11.6.3. Product Portfolio
11.6.4. Strategic Initiatives